Behrndt-Eriksen Mads Nikolaj bought COAG
January 29, 2026 · Form 4 insider transaction
Behrndt-Eriksen Mads Nikolaj bought 195,206 shares of Hemab Therapeutics Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 95 days after the transaction.
Direction
Acquired (buy-side)
Shares
195,206
Price
$0.00
Total value
N/A
InsiderBehrndt-Eriksen Mads Nikolaj
RoleOfficer
SecurityWarrants (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 29, 2026
Filing dateMay 4, 2026
Shares owned after195,206
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The warrant was granted on January 29, 2026. The shares underlying the warrant vest over four years, with 25% of the shares vesting on January 1, 2027 and the remaining shares vesting in equal monthly installments thereafter.